<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266699/" ref="ordinalpos=2609&amp;ncbi_uid=6969047&amp;link_uid=PMC4266699" image-link="/pmc/articles/PMC4266699/figure/fig01/" class="imagepopup">Figure 1.  From: Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors. </a></div><br /><div class="p4l_captionBody">HER family and EGFR signaling pathway. Ligand-bound receptors form functionally active homodimers or heterodimers, resulting in the activation of downstream signaling pathways such as PI3K/AKT, RAS/RAF/MAPK, PLCÎ³/PKC and JAK/STAT pathway, leading to cell proliferation, invasion, metastasis, survival and angiogenesis.</div></div>